Results 21 to 30 of about 1,083 (145)
Giant prolactinoma: case report and review of literature [PDF]
Journal of Diabetes and Metabolic Disorders, 2013 Abstract“Invasive giant prolactinoma” is a large prolactinoma (>4 cm in dimension) presenting with serum prolactin levels of >1000 ng/dL and mass related clinical symptoms. Here we report a patient with a giant prolactinoma presented with central hypogonadism, suppressed adrenal and thyroid function, supra sellar extension, visual field ...
Bagher Larijani, Masoud Rahmanian
exaly +3 more sources
Atypical giant prolactinoma with frontal lobe manifestations. [PDF]
BMJ Case Rep, 2018 Prolactinomas having the diameter above 4 cm are termed ‘giant prolactinomas’.1 2 Their incidence is approximately 2%–3% of all prolactinomas1. These are associated with very high prolactin concentration and numerous neurological sequelae, arising from their extension into surrounding structures.
Arshad MF, Arambewela M, Debono M.
europepmc +4 more sources
Ten-year follow-up of a giant prolactinoma. [PDF]
BMJ Case Rep, 2015 Giant prolactinomas are rare pituitary tumours of which management can be a challenge. A 28-year-old man presented with headaches, visual impairment and behavioural changes. Clinically, the patient was found to have hypogonadism and bitemporal hemianopsia.
Fernandes V +3 more
europepmc +5 more sources
Skeletal assessment in giant prolactinoma: a reply [PDF]
Endocrine JournalAysel Unver Ozkahraman, Esra Hatipoglu
doaj +2 more sources
Beyond tumor control: skeletal morbidity in giant prolactinoma [PDF]
Endocrine JournalTaner Dandinoğlu
doaj +2 more sources
Therapeutic challenges of giant invasive cystic macroprolactinoma [PDF]
Endocrinology, Diabetes & Metabolism Case ReportsGiant cystic prolactinomas are extremely rare, with only four cases previously reported in the literature. Herein, we report the case of a 59-year-old male who presented with an acute decline in visual acuity.
S Mekni +6 more
doaj +2 more sources
Correlation between serum endocrine hormone levels and malignancy degree of prolactinoma and their predictive value for patient prognosis [PDF]
Scientific ReportsTo investigate the correlation between serum endocrine hormone levels and the malignancy degree of prolactinomas, and analyze their predictive value for patient prognosis. A total of 100 prolactinoma patients admitted to the Affiliated Hospital of Xuzhou
Peimin Yu +5 more
doaj +2 more sources
BMC Endocrine Disorders, 2023 Background Giant prolactinoma (> 4 cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus.
Danting Li +4 more
doaj +1 more source
Turkish Journal of Internal Medicine, 2022 Objective: Data on whether there is a histopathological difference in cellular features as determined with Ki-67 between giant prolactinomas and smaller macroprolactinomas are not fully clear.
Soner Cander, Özen Öz Gül
doaj +1 more source
Giant prolactinomas in women [PDF]
European Journal of Endocrinology, 2014 ObjectiveTo characterise distinctive clinical features of giant prolactinomas in women.DesignA multicentre, retrospective case series and literature review.MethodsWe collected data from 15 female patients with a pituitary tumour larger than 4 cm and prolactin levels above 1000 μg/l and identified 19 similar cases from the literature; a gender-based ...
Delgrange, Etienne +8 more
openaire +4 more sources